Dihexa (PNB-0408) is a synthetic oligopeptide derived from angiotensin IV, developed at Washington State University in the laboratory of Dr Joseph Harding
Comparative peptide pharmacology remains another important area of investigation
Setting realistic expectations ensures patients stay the course long enough to see the full benefit of their investment
Marketed as a multitasking anti-aging and regenerative molecule, GHK-Cu is now positioned as a next-generation active for skin repair, collagen induction, and antioxidant defense
Studies examining safety and tolerability in rodents have generally not reported concerning toxicity signals at doses producing metabolic benefits, though comprehensive toxicology studies and long-term safety data are limited
In contrast, impaired tissue glucose uptake in response to insulin (a phenomenon called insulin resistance) plays a key role in the development of type 2 diabetes (55)